Perceived efficacy and satisfaction of patients with subcutaneous hypoallergenic high-dose house dust mite extract

Autor: A, Roger Reig, M, Ibero Iborra, T, Carrillo Díaz, R, López Abad, V, Sánchez Moreno, J, Álvarez Nieto, N, Cancelliere

Publikováno v: European annals of allergy and clinical immunology. 49(3)

The efficacy and safety of subcutaneous immunotherapy with modified, high-dose, major allergen house dust mite extract is widely supported by double-blind, placebo-controlled studies. However, little is known regarding patient-perceived efficacy and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aa78e5f557f397c6582120f2ea8f3a70
https://pubmed.ncbi.nlm.nih.gov/28497671

Perceived efficacy and satisfaction of patients with subcutaneous hypoallergenic high-dose house dust mite extract.

Autor: Roger Reig A; Allergy Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain., Ibero Iborra M; Allergy Unit, Hospital de Terrassa, Barcelona, Spain., Carrillo Díaz T; Allergy Unit, Hospital Universitario Dr Negrín, Las Palmas de Gran Canaria, Spain., López Abad R; Allergy Unit, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Sánchez Moreno V; Allergy Division, Hospital Universitario del Henares, Coslada, Spain., Álvarez Nieto J; Medical Affairs Department, Merck SLU, Calle María de Molina 40, Madrid, Spain., Cancelliere N; Medical Affairs Department, Merck SLU, Calle María de Molina 40, Madrid, Spain. Phone: +34 917 45 44 00 Fax: +34 917 454 444 E-mail: nataly.cancelliere@merckgroup.com.

Publikováno v: European annals of allergy and clinical immunology [Eur Ann Allergy Clin Immunol] 2017 May; Vol. 49 (3), pp. 100-105.